Roy A Beveridge,'s Net Worth
$16.7 Million
Who is Roy A Beveridge,?
Roy A Beveridge, has an estimated net worth of $16.7 Million. This is based on reported shares across multiple companies, which include HUMANA INC, and Epizyme, Inc..
SEC CIK
Roy A Beveridge,'s CIK is 0001579300
Past Insider Trading and Trends
2018 was Roy A Beveridge,'s most active year for acquiring shares with 9 total transactions. Roy A Beveridge,'s most active month to acquire stocks was the month of January. 2018 was Roy A Beveridge,'s most active year for disposing of shares, totalling 14 transactions. Roy A Beveridge,'s most active month to dispose stocks was the month of November. 2018 saw Roy A Beveridge, paying a total of $2,560,948.24 for 27,094 shares, this is the most they've acquired in one year. In 2017 Roy A Beveridge, cashed out on 72,404 shares for a total of $8,533,477.24, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
HUMANA INC (HUM) Snapshot price: $357.65
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -8.66% | -1.02K |
$237.49 | -$1,353,755.57 | 10.79K |
Feb 19 - Feb 20
| |||
Form 4
| +11.23% | 1.19K |
$304.05 | -$329,584.78 | 11.81K |
Dec 15
| |||
Form 4
| -30.32% | -4.62K |
$341.06 | -$1,576,395.50 | 10.62K |
Nov 8
| |||
Form 4
| +9.01% | 1.26K |
$241.12 | -$2,283,708.02 | 15.24K |
Aug 6
| |||
Form 4
| -0.74% | -104.00 |
—
|
—
| 13.98K |
May 18
| |||
Form 4
| +17.77% | 2.13K |
$269.31 | -$282,236.88 | 14.09K |
Feb 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
| +8.71% | 958 |
$253.62 | -$247,786.74 | 11.96K |
Dec 15
| |||
Form 4
| +2.95% | 2.07K |
$161.94 | -$3,621,540.14 | 72.26K |
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
| +14.68% | 1.14K |
$205.53 | -$1,954,189.48 | 8.93K |
Feb 18 - Feb 22
| |||
Form 4
| +48.06% | 2.53K |
$141.53 | -$506,667.22 | 7.79K |
Dec 20
| |||
Form 4
| +11.46% | 541 |
$206.60 | -$113,833.84 | 5.26K |
Dec 15
| |||
Form 4
|
∞
| 4.72K |
$186.67 | -$602,554.62 | 4.72K |
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Epizyme, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -46.04K |
—
|
—
|
0
|
Aug 12
| |||
Form 4
| +24.06% | 8.93K |
$1.47 | $13,124.16 | 46.04K |
Jun 30
| |||
Form 4
| +31.99% | 8.99K |
—
|
—
| 37.11K |
May 17
| |||
Form 4
| +68.33% | 11.41K |
$1.15 | $13,124.95 | 28.11K |
Mar 31
| |||
Form 4
|
∞
| 16.7K |
—
|
—
| 16.7K |
Nov 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |